France: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in France

In 2021, the French medicaments containing insulin market decreased by -28.4% to $X, falling for the second year in a row after two years of growth. Over the period under review, consumption continues to indicate a slight contraction. Medicaments containing insulin consumption peaked at $X in 2019; however, from 2020 to 2021, consumption remained at a lower figure.

Medicaments Containing Insulin Production in France

In value terms, medicaments containing insulin production stood at $X in 2021 estimated in export price. Over the period under review, production saw a relatively flat trend pattern. The pace of growth was the most pronounced in 2016 with an increase of 29% against the previous year. As a result, production attained the peak level of $X. From 2017 to 2021, production growth remained at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports from France

In 2021, approx. X tons of medicaments containing insulin but not antibiotics were exported from France; reducing by -81.2% compared with the year before. In general, exports, however, enjoyed a strong increase. The growth pace was the most rapid in 2020 when exports increased by 477%. As a result, the exports reached the peak of X tons, and then shrank sharply in the following year.

In value terms, medicaments containing insulin exports contracted markedly to $X in 2021. Overall, exports, however, saw resilient growth. The most prominent rate of growth was recorded in 2020 when exports increased by 351% against the previous year. As a result, the exports attained the peak of $X, and then dropped significantly in the following year.

Exports by Country

New Caledonia (X kg), French Polynesia (X kg) and the UK (X kg) were the main destinations of medicaments containing insulin exports from France, with a combined 100% share of total exports.

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by New Caledonia (with a CAGR of +23.0%), while the other leaders experienced more modest paces of growth.

In value terms, New Caledonia ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics exports from France, comprising 59% of total exports. The second position in the ranking was held by French Polynesia ($X), with a 27% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of value to New Caledonia amounted to +21.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: French Polynesia (+6.3% per year) and the UK (0.0% per year).

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, with an increase of 28% against the previous year. Overall, the export price, however, continues to indicate a slight curtailment. The growth pace was the most rapid in 2016 an increase of 48% against the previous year. Over the period under review, the average export prices reached the peak figure at $X per ton in 2012; however, from 2013 to 2021, the export prices remained at a lower figure.

There were significant differences in the average prices for the major export markets. In 2021, amid the top suppliers, the country with the highest price was New Caledonia ($X per ton), while the average price for exports to the UK ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the United Arab Emirates (+15.5%), while the prices for the other major destinations experienced a decline.

Medicaments Containing Insulin Imports

Imports into France

In 2021, supplies from abroad of medicaments containing insulin but not antibiotics decreased by -98.1% to X kg for the first time since 2011, thus ending a nine-year rising trend. Over the period under review, imports saw a drastic downturn. The pace of growth appeared the most rapid in 2020 when imports increased by 73% against the previous year. As a result, imports attained the peak of X tons, and then dropped significantly in the following year.

In value terms, medicaments containing insulin imports fell markedly to $X in 2021. In general, imports saw a deep contraction. The most prominent rate of growth was recorded in 2020 with an increase of 83%. As a result, imports attained the peak of $X, and then dropped rapidly in the following year.

Imports by Country

In 2021, Denmark (X kg) was the main supplier of medicaments containing insulin to France, accounting for a approx. 98% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of volume from Denmark stood at -25.6%.

In value terms, Denmark ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to France.

From 2012 to 2021, the average annual growth rate of value from Denmark amounted to -24.0%.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, dropping by -1.8% against the previous year. Over the last nine years, it increased at an average annual rate of +1.4%. The pace of growth appeared the most rapid in 2020 an increase of 5.6% against the previous year. As a result, import price attained the peak level of $X per ton, and then fell slightly in the following year.

As there is only one major supplying country, the average price level is determined by prices for Denmark.

From 2012 to 2021, the rate of growth in terms of prices for Denmark amounted to +2.2% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :